Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.5 - $31.51 $8,899 - $10,996
-349 Reduced 4.36%
7,651 $218,000
Q1 2024

May 02, 2024

SELL
$27.7 - $35.48 $3,545 - $4,541
-128 Reduced 1.57%
8,000 $233,000
Q4 2023

Jan 26, 2024

SELL
$26.32 - $34.31 $210 - $274
-8 Reduced 0.1%
8,128 $274,000
Q3 2023

Nov 09, 2023

SELL
$30.68 - $40.09 $25,985 - $33,956
-847 Reduced 9.43%
8,136 $249,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $47.5 $16,795 - $22,087
-465 Reduced 4.92%
8,983 $359,000
Q1 2023

May 04, 2023

SELL
$35.53 - $43.38 $5,969 - $7,287
-168 Reduced 1.75%
9,448 $385,000
Q4 2022

Feb 10, 2023

BUY
$38.19 - $57.45 $19,056 - $28,667
499 Added 5.47%
9,616 $371,000
Q3 2022

Nov 08, 2022

BUY
$51.24 - $58.89 $76,142 - $87,510
1,486 Added 19.47%
9,117 $485,000
Q2 2022

Aug 10, 2022

BUY
$51.49 - $81.64 $62,405 - $98,947
1,212 Added 18.88%
7,631 $445,000
Q1 2022

May 02, 2022

BUY
$60.03 - $76.49 $19,989 - $25,471
333 Added 5.47%
6,419 $490,000
Q4 2021

Feb 03, 2022

BUY
$47.97 - $62.21 $7,579 - $9,829
158 Added 2.67%
6,086 $366,000
Q3 2021

Nov 10, 2021

SELL
$54.64 - $61.3 $18,085 - $20,290
-331 Reduced 5.29%
5,928 $332,000
Q2 2021

Aug 06, 2021

BUY
$59.18 - $69.99 $23,731 - $28,065
401 Added 6.85%
6,259 $380,000
Q1 2021

May 13, 2021

BUY
$59.31 - $78.82 $26,392 - $35,074
445 Added 8.22%
5,858 $411,000
Q4 2020

Feb 12, 2021

BUY
$50.47 - $66.26 $12,516 - $16,432
248 Added 4.8%
5,413 $324,000
Q3 2020

Nov 13, 2020

BUY
$51.97 - $63.0 $161,730 - $196,056
3,112 Added 151.58%
5,165 $311,000
Q2 2020

Aug 06, 2020

BUY
$30.8 - $52.47 $6,437 - $10,966
209 Added 11.33%
2,053 $108,000
Q1 2020

May 11, 2020

BUY
$28.4 - $50.7 $9,173 - $16,376
323 Added 21.24%
1,844 $62,000
Q4 2019

Feb 11, 2020

SELL
$36.31 - $46.83 $580 - $749
-16 Reduced 1.04%
1,521 $69,000
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $54,809 - $69,149
1,537 New
1,537 $59,000
Q2 2019

Aug 12, 2019

SELL
$36.57 - $47.97 $3.22 Million - $4.23 Million
-88,124 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$36.47 - $42.17 $1.74 Million - $2.01 Million
-47,655 Reduced 35.1%
88,124 $3.35 Million
Q4 2018

Feb 12, 2019

SELL
$41.31 - $52.16 $466,348 - $588,834
-11,289 Reduced 7.68%
135,779 $5.84 Million
Q3 2018

Nov 13, 2018

SELL
$32.85 - $52.0 $278,765 - $441,272
-8,486 Reduced 5.46%
147,068 $7.23 Million
Q2 2018

Aug 09, 2018

BUY
$27.5 - $39.8 $566,665 - $820,118
20,606 Added 15.27%
155,554 $4.99 Million
Q1 2018

May 11, 2018

SELL
$29.98 - $46.35 $536,911 - $830,082
-17,909 Reduced 11.72%
134,948 $4.2 Million
Q4 2017

Jan 31, 2018

BUY
$31.85 - $46.95 $56,661 - $83,524
1,779 Added 1.18%
152,857 $6.98 Million
Q3 2017

Oct 18, 2017

BUY
$35.7 - $39.5 $5.39 Million - $5.97 Million
151,078
151,078 $5.67 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.